Matthew Cutler

Matthew Cutler

Harness, Dickey & Pierce, PLC

Contact  |  View Bio  |  RSS

Latest Publications

Share:

Board Explains the Process for Evidentiary Objections—and Illustrates the Severe Penalty for Not Following It

Practitioners who are used to district court litigation may be surprised—and tripped up—by the rules for objecting to evidence in IPRs, which differ significantly from the approach used in litigation. The Board’s Final...more

2/9/2016 - Corporate Counsel Federal Rules of Evidence Inter Partes Review Proceedings Motion to Exclude Objections Patent Owner Preliminary Response Patent Trial and Appeal Board Supplemental Evidence Young Lawyers

BioPharma Patents: Quick Tips & News - January 2016

Subject matter eligibility and “laws of nature.” As reported in our July 2015 newsletter, the Federal Circuit invalidated claims to a method of diagnosing fetal abnormalities without amniocentesis. This precedent—if it...more

2/1/2016 - Inter Partes Review Proceedings Merck Patent Invalidity Patent Litigation Patent Trial and Appeal Board Patent-Eligible Subject Matter Pharmaceutical Patents Preponderance of the Evidence Reduction to Practice Terminal Disclaimer USPTO

Federal Circuit Issues Ironic Decision Reversing PTAB For Not Providing Enough Analysis

The PTAB was rebuked by the Federal Circuit on January 22nd for failing to provide an adequate description of its reasoning for finding the claims of the challenged patent obvious in an inter partes review proceeding. In...more

1/29/2016 - Inter Partes Review Proceedings Obviousness Patent Litigation Patent Trial and Appeal Board Rule 36

“Obvious to Try” Rationale Insufficient to Institute IPR Trial Directed to Venlafaxine

The rate at which the Board denies inter partes review petitions has been climbing in recent months, and will be helped along by the Board’s denial of review in Neptune Generics v. Auspex Pharm., IPR2015-01313. Neptune...more

1/15/2016 - Inter Partes Review Proceedings Patent Litigation Patent Trial and Appeal Board Pharmaceutical Patents Prior Art

PTAB Rejects Challenge to Onglyza® Patent

The lower burden of proof associated with inter partes reviews should make IPRs attractive to generic pharmaceutical companies, but even with that lower burden, success is not guaranteed, as illustrated by IPR2015-01340. ...more

12/23/2015 - AstraZeneca Generic Drugs Inter Partes Review Proceedings Mylan Pharmaceuticals Obviousness Patent Litigation Patent Trial and Appeal Board Pharmaceutical Patents

Federal Circuit Addresses Substantial Evidence as Standard of Review in IPR

In June, 2014, the PTAB declared all challenged claims in two IPR trials brought by Gnosis S.p.A. to be unpatentable based on obviousness grounds. Gnosis S.p.A. v. S. Ala. Medical Science Found., IPR2013-00116 and Gnosis...more

12/18/2015 - Inter Partes Review Proceedings Merck Obviousness Patent Litigation Patent Trial and Appeal Board Preponderance of the Evidence Substantial Evidence Standard

The PTAB Can Institute Post Grant Trial on a Legal Ground Not Raised in the Petition

In In re Cuozzo Speed Tech., the patentee tried (and failed) to challenge the Board’s decision to institute an IPR on the basis of a combination of references that the petitioner had never suggested. However, even in Cuozzo...more

12/16/2015 - Anticipation Apple Covered Business Method Proceedings Inter Partes Review Proceedings Obviousness Patent Trial and Appeal Board Post-Grant Review

Sec. 103(c) Saves Patent Claims in IPR Final Written Decision

In a recently-issued Final Written Decision, the Board thoroughly explained the sometimes tricky issue of the shift, if any, of the burden of proof/production in an IPR proceeding. Global Tel*Link Corp. v. Securus Techs.,...more

12/10/2015 - Burden of Proof Inter Partes Review Proceedings Patent Litigation Patent Trial and Appeal Board Popular Prior Art

Federal Circuit Upholds Constitutionality of Post-Issuance Trials

Last week, the Federal Circuit held in MCM Portfolio LLC v. Hewlett-Packard Co., _____ F.3d _____ (Fed. Cir. 2015) that inter partes review trials do not violate Article III and the Seventh Amendment of the...more

12/8/2015 - Article III Hewlett-Packard Inter Partes Review Proceedings Post-Grant Review SCOTUS Seventh Amendment USPTO

Federal Circuit Weighs in on IPR Again, and Judge Newman Regains Her Footing as Pro-Patent Crusader

The Federal Circuit issued another substantive, IPR-related opinion today in Prolitec, Inc. v. ScentAir Techs., Inc., 2015-1020 (Fed. Cir. Dec. 4, 2015) (appealing from IPR2013-00179). The Board had determined that each of...more

12/7/2015 - Anticipation Claim Construction Inter Partes Review Proceedings Motion to Amend Patent Trial and Appeal Board Substantial Evidence Standard

PTAB Finds Different Claim Terms Have the Same Meaning

One of the classic canons of claim construction is that different claim terms in a patent are presumed to have different meanings. The Board found an exception to that general rule in Air Liquide Large Indus. v. Praxair...more

12/1/2015 - Broadest Reasonable Interpretation Standard Claim Construction Patent Litigation Patent Trial and Appeal Board Patents Young Lawyers

Federal Circuit Issues Second Reversal in Favor of a Patent Owner

The Federal Circuit has picked up the pace of issuing actual written opinions regarding PTAB decisions, instead of its previous, steady diet of Rule 36 Judgments. Today, the Court issued its second opinion reversing a Board...more

11/30/2015 - Claim Construction Inter Partes Review Proceedings Patent Litigation Patent Trial and Appeal Board Plain Meaning Popular Reversal

3 Years of Inter Partes Review – By The Numbers

Welcome to Harness Dickey’s Report on Litigation Practice before the United States Patent Office. Created by the America Invents Act, Inter Partes Review proceedings have already changed the face of patent litigation. Lower...more

11/25/2015 - Inter Partes Review Proceedings Motion to Amend Motion To Stay Patent Litigation Patent Owner Preliminary Response Patent Trial and Appeal Board Patents Young Lawyers

PTAB’s Ambiguous Language Is Basis For Federal Circuit Vacating PTAB’s Opinion

Yesterday, the Federal Circuit remanded a PTAB decision for just the second time. In Ariosa Diagnostics v. Verinata Health, Inc., the Federal Circuit vacated and remanded the Board’s decision upholding the validity of...more

11/18/2015 - Ambiguous Patent Trial and Appeal Board Patents Popular Prior Art Remand Vacated

Board Offers New Technique to Solve an Often-Raised IPR Issue

One panel of the PTAB has introduced a technique that may help solve the oft-raised complaint that a reply brief from Petitioner contains new evidence and/or argument not raised in the Petition. In early decisions, when this...more

11/12/2015 - Evidence Inter Partes Review Proceedings Patent Litigation Patent Trial and Appeal Board Patents

Lessons Learned from a Rare CAFC Opinion on an IPR Matter

To date, the Federal Circuit has issued Rule 36 affirmances in over 80% of the cases it has heard. Thus, when a new, substantive opinion is issued by the Court, it is an opportunity to learn. On November 5th, the Federal...more

11/10/2015 - CAFC Inter Partes Review Proceedings Patent Litigation Patent Trial and Appeal Board Patents Popular Rule 36

Don’t Let Protective Orders Trip Up Your IPR Strategy

The PTAB recently addressed what is a common – but unnecessary – problem created by a protective order issued in a parallel Federal District Court litigation. In B/E Aerospace Industries, LLC v. MAG Aerospace Industries,...more

11/6/2015 - Additional Discovery Confidential Information Discovery Inter Partes Review Proceedings Issue Preclusion Parallel Claims Patent Infringement Patent Litigation Patent Trial and Appeal Board Patent-in-Suit Patents Protective Orders Young Lawyers

Federal Circuit Clarity on Key IPR Issues May Be on the Way

We are entering an interesting phase in the development of inter partes review proceedings as more and more of the contours of these proceedings are being heard by the Federal Circuit. To date, the Federal Circuit has made...more

11/5/2015 - Appeals Apple CAFC Inter Partes Review Proceedings Patent Infringement Patent Litigation Patent Trial and Appeal Board Patents Popular Rule 36

Split 5-Judge Panel Allows Issue Joinder as a Way Around the One-Year Filing Deadline

The Board continues to grapple with the issue of joinder where a party seeks to join a petition that would otherwise be time-barred with an earlier-filed petition. In Zhongshan v. Nidec Motor, an expanded 5-judge panel–with...more

10/19/2015 - Filing Deadlines Inter Partes Review Proceedings Joinder Patent Infringement Patent Litigation Patent Trial and Appeal Board Patents Petition For Rehearing Prior Art Public Interest

BioPharma Patents: Quick Tips & News - September 2015

For our BioPharma audience, you might be interested in Harness Dickey’s Quarterly BioPharma Newsletter, which reports on the impact of the Akamai v. Limelight, Suprema v. ITC, and Amgen v. Sandoz cases on the BioPharma...more

9/17/2015 - Biosimilars BPCIA Direct Infringement Eli Lilly En Banc Review FDA Approval Imports Induced Infringement ITC Limelight v Akamai Method Claims Patent Dance Patent Infringement Patent Litigation Patents Pharmaceutical Patents Prescription Drugs Sandoz v Amgen Suprema Teva Pharmaceuticals

PTAB Eases Restrictions on Submitting Observations on Cross Examination for Your Own Witness

When a party submits declaration testimony and the opposing party is not entitled to another brief, “observations on cross-examination” are the opposing party’s mechanism for introducing declaration testimony from that...more

9/16/2015 - Cross Examination Declaration Federal Rules of Evidence Inter Partes Review Proceedings Patent Infringement Patent Litigation Patent Trial and Appeal Board Patents Witness Statements

PGR Order Offers Insight Into Successful and Unsuccessful Discovery Requests

Parties to inter partes review and post grant review proceedings have continued to struggle to find the right formula in successfully navigating the PTAB’s requirements for a motion for additional discovery. In American...more

9/10/2015 - Additional Discovery Bias Consideration Discovery Garmin Factors Inter Partes Review Proceedings Patent Infringement Patent Litigation Patent Trial and Appeal Board Patents Post-Grant Review Real Party in Interest

Don’t Count on Avoiding a Redundancy Finding by Filing Multiple IPR Petitions

From the very outset of inter partes review proceedings, the Board has helped to manage its docket by rejecting challenge grounds in petitions that are redundant to other grounds in the petition. See Liberty Mutual Ins. Co....more

9/3/2015 - Inter Partes Review Proceedings Patent Infringement Patent Litigation Patent Trial and Appeal Board Patents Petition For Rehearing

PTAB Finds Copyright Notice is Inadmissible Hearsay – Denies Petition for IPR

Different panels of the Patent Trial and Appeal Board have, for the most part, agreed with each other on many of the key issues that arise in inter partes review proceedings. There are, however, instances of disagreement and...more

9/1/2015 - Copyright Hearsay Hewlett-Packard Inadmissible Evidence Inter Partes Review Proceedings Patent Infringement Patent Litigation Patent Trial and Appeal Board Patents Prior Art

First One Gets Away from Bass-Backed Group

Many in the pharmaceutical industry have been concerned about becoming a target of the Coalition for Affordable Drugs, the group backed by hedge fund manager Kyle Bass. But yesterday the first target of Bass’s strategy,...more

8/27/2015 - Hedge Funds Inter Partes Review Proceedings Orange Book Patent Infringement Patent Litigation Patent Trial and Appeal Board Patents Pharmaceutical Patents Prior Art

152 Results
|
View per page
Page: of 7

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.
×